• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

YAP-TEAD 通过上调 IRS2 表达诱导并恶化食管癌。

YAP-TEAD up-regulates IRS2 expression to induce and deteriorate oesophageal cancer.

机构信息

Department of Gastroenterology, Linyi People's Hospital, Linyi, China.

出版信息

J Cell Mol Med. 2021 Mar;25(5):2584-2595. doi: 10.1111/jcmm.16266. Epub 2021 Feb 11.

DOI:10.1111/jcmm.16266
PMID:33570213
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7933937/
Abstract

Oesophageal cancer (EC) represents a significant cause of cancer worldwide. Yes-associated protein (YAP) is reported to correlate with the initiation of multiple cancers including EC, but the underlying mechanism remains elusive. The current study aimed to investigate the molecular mechanism of YAP-TEAD in the occurrence and progression of EC. EC tissues and cells were obtained, followed by determination of the expression of YAP, c-Jun, pc-Jun and IRS2. The effect of YAP-TEAD on the biological EC cell processes was explored through gain- and loss-of-function approaches. The interaction between YAP and TEAD was detected by co-immunoprecipitation. The binding of TEAD to the c-Jun promoter was determined using chromatin immunoprecipitation. Tumour formation in the nude mice was detected in order to ascertain the effect of YAP and IRS2 in vivo. We found elevated YAP in the EC tissues and cells. YAP silencing led to a decrease in EC cell proliferation, invasion and sphere formation. YAP-TEAD complex bound to the promotor of c-Jun, and c-Jun led to an increase in the expression of IRS2 through the JNK/c-Jun pathway. Additionally, pc-Jun and phosphorylated JNK were localized in the nuclear in addition to displaying enhanced expression in the EC tissues. IRS2 overexpression negated the inhibition of cell proliferation, invasion and sphere formation triggering YAP silencing. YAP up-regulated IRS2 and aggravated EC in vivo. Taken together, YAP-TEAD activates the JNK/c-Jun pathway to up-regulate IRS2, ultimately promoting EC progression. Therefore, YAP-TEAD inhibition could be a promising therapeutic approach for EC treatment.

摘要

食管癌(EC)是全球范围内癌症的主要病因之一。研究表明,Yes 相关蛋白(YAP)与多种癌症的发生有关,包括 EC,但潜在机制尚不清楚。本研究旨在探讨 YAP-TEAD 在 EC 发生和发展中的分子机制。本研究获取 EC 组织和细胞,检测 YAP、c-Jun、pc-Jun 和 IRS2 的表达。通过增益和失活功能方法探索 YAP-TEAD 对 EC 细胞生物学过程的影响。通过免疫共沉淀检测 YAP 与 TEAD 的相互作用。通过染色质免疫沉淀检测 TEAD 与 c-Jun 启动子的结合。通过裸鼠肿瘤形成实验检测 YAP 和 IRS2 在体内的作用。我们发现 EC 组织和细胞中 YAP 水平升高。YAP 沉默导致 EC 细胞增殖、侵袭和球体形成减少。YAP-TEAD 复合物结合到 c-Jun 的启动子上,c-Jun 通过 JNK/c-Jun 通路增加 IRS2 的表达。此外,pc-Jun 和磷酸化 JNK 定位于核内,并且在 EC 组织中表达增强。IRS2 过表达可抵消 YAP 沉默引起的细胞增殖、侵袭和球体形成抑制。YAP 上调 IRS2 并加重体内 EC。综上所述,YAP-TEAD 通过激活 JNK/c-Jun 通路上调 IRS2,最终促进 EC 的进展。因此,抑制 YAP-TEAD 可能是治疗 EC 的一种有前途的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cdb/7933937/525e033f11cb/JCMM-25-2584-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cdb/7933937/a02364845da9/JCMM-25-2584-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cdb/7933937/7c220df8bec6/JCMM-25-2584-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cdb/7933937/c541424884de/JCMM-25-2584-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cdb/7933937/dd024d1b8be5/JCMM-25-2584-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cdb/7933937/ed61ee86d7ea/JCMM-25-2584-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cdb/7933937/525e033f11cb/JCMM-25-2584-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cdb/7933937/a02364845da9/JCMM-25-2584-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cdb/7933937/7c220df8bec6/JCMM-25-2584-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cdb/7933937/c541424884de/JCMM-25-2584-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cdb/7933937/dd024d1b8be5/JCMM-25-2584-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cdb/7933937/ed61ee86d7ea/JCMM-25-2584-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cdb/7933937/525e033f11cb/JCMM-25-2584-g006.jpg

相似文献

1
YAP-TEAD up-regulates IRS2 expression to induce and deteriorate oesophageal cancer.YAP-TEAD 通过上调 IRS2 表达诱导并恶化食管癌。
J Cell Mol Med. 2021 Mar;25(5):2584-2595. doi: 10.1111/jcmm.16266. Epub 2021 Feb 11.
2
Blockage of glioma cell survival by truncated TEAD-binding domain of YAP.YAP 截断 TEAD 结合域阻断神经胶质瘤细胞存活。
J Cancer Res Clin Oncol. 2021 Jun;147(6):1713-1723. doi: 10.1007/s00432-021-03577-8. Epub 2021 Mar 2.
3
CRKL Enhances YAP Signaling through Binding and JNK/JUN Pathway Activation in Liver Cancer.CRKL 通过与 JNK/JUN 通路的结合及激活增强肝癌中的 YAP 信号。
Int J Mol Sci. 2024 Aug 5;25(15):8549. doi: 10.3390/ijms25158549.
4
PDK-1 mediated Hippo-YAP-IRS2 signaling pathway and involved in the apoptosis of non-small cell lung cancer cells.PDK-1 介导的 Hippo-YAP-IRS2 信号通路,并参与非小细胞肺癌细胞的凋亡。
Biosci Rep. 2019 May 14;39(5). doi: 10.1042/BSR20182099. Print 2019 May 31.
5
Yes-associated protein/TEA domain family member and hepatocyte nuclear factor 4-alpha (HNF4α) repress reciprocally to regulate hepatocarcinogenesis in rats and mice.Yes 相关蛋白/TEA 结构域家族成员和肝细胞核因子 4-α(HNF4α)相互抑制调节大鼠和小鼠肝癌的发生。
Hepatology. 2017 Apr;65(4):1206-1221. doi: 10.1002/hep.28911. Epub 2016 Dec 19.
6
Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.E3 泛素连接酶 PARK2 调控 Hippo/YAP 信号通路及食管鳞癌的进展
Theranostics. 2020 Jul 25;10(21):9443-9457. doi: 10.7150/thno.46078. eCollection 2020.
7
Organ of Corti size is governed by Yap/Tead-mediated progenitor self-renewal.柯蒂氏器的大小由Yap/Tead介导的祖细胞自我更新决定。
Proc Natl Acad Sci U S A. 2020 Jun 16;117(24):13552-13561. doi: 10.1073/pnas.2000175117. Epub 2020 Jun 1.
8
A transcriptional cofactor YAP regulates IFNT expression via transcription factor TEAD in bovine conceptuses.转录辅因子YAP通过转录因子TEAD调节牛孕体中的IFNT表达。
Domest Anim Endocrinol. 2016 Oct;57:21-30. doi: 10.1016/j.domaniend.2016.05.002. Epub 2016 May 17.
9
YAP-Dependent BiP Induction Is Involved in Nicotine-Mediated Oral Cancer Malignancy.YAP 依赖性 BiP 诱导参与尼古丁介导的口腔癌恶性转化。
Cells. 2021 Aug 13;10(8):2080. doi: 10.3390/cells10082080.
10
Activated hippo signal pathway inhibits cell proliferation and promotes apoptosis in NK/T cell lymphoma cells.激活的 hippo 信号通路抑制 NK/T 细胞淋巴瘤细胞的增殖并促进其凋亡。
Cancer Med. 2019 Jul;8(8):3892-3904. doi: 10.1002/cam4.2174. Epub 2019 May 23.

引用本文的文献

1
YAP as a therapeutic target in esophageal squamous cell carcinoma: insights and strategies.YAP作为食管鳞状细胞癌的治疗靶点:见解与策略
Ann Med. 2025 Dec;57(1):2536200. doi: 10.1080/07853890.2025.2536200. Epub 2025 Jul 22.
2
FOXG1 regulates the proliferation and apoptosis of human lung cancer cells.FOXG1调节人肺癌细胞的增殖和凋亡。
Heliyon. 2023 Aug 26;9(9):e19540. doi: 10.1016/j.heliyon.2023.e19540. eCollection 2023 Sep.
3
C12orf59 Promotes Esophageal Squamous Cell Carcinoma Progression YAP-Mediated Epithelial-Mesenchymal Transition.

本文引用的文献

1
A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy.针对癌症治疗的 YAP/TAZ-TEAD 癌蛋白的斗争。
Theranostics. 2020 Feb 18;10(8):3622-3635. doi: 10.7150/thno.40889. eCollection 2020.
2
Selective inhibitors for JNK signalling: a potential targeted therapy in cancer.选择性 JNK 信号通路抑制剂:癌症潜在的靶向治疗方法。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):574-583. doi: 10.1080/14756366.2020.1720013.
3
Yes-associated protein (YAP) predicts poor prognosis and regulates progression of esophageal squamous cell cancer through epithelial-mesenchymal transition.
C12orf59通过YAP介导的上皮-间质转化促进食管鳞状细胞癌进展
Front Oncol. 2022 Jul 4;12:927249. doi: 10.3389/fonc.2022.927249. eCollection 2022.
4
An Integrative Pan-Cancer Analysis Revealing MLN4924 (Pevonedistat) as a Potential Therapeutic Agent Targeting Skp2 in YAP-Driven Cancers.一项综合泛癌分析揭示MLN4924(pevonedistat)作为YAP驱动癌症中靶向Skp2的潜在治疗药物。
Front Genet. 2022 May 24;13:866702. doi: 10.3389/fgene.2022.866702. eCollection 2022.
5
TEAD4 as an Oncogene and a Mitochondrial Modulator.TEAD4作为一种癌基因和线粒体调节剂。
Front Cell Dev Biol. 2022 May 5;10:890419. doi: 10.3389/fcell.2022.890419. eCollection 2022.
Yes相关蛋白(YAP)可预测预后不良,并通过上皮-间质转化调节食管鳞状细胞癌的进展。
Exp Ther Med. 2019 Oct;18(4):2993-3001. doi: 10.3892/etm.2019.7896. Epub 2019 Aug 14.
4
The posttranslational modifications of Hippo-YAP pathway in cancer.Hippo-YAP 通路在癌症中的翻译后修饰。
Biochim Biophys Acta Gen Subj. 2020 Jan;1864(1):129397. doi: 10.1016/j.bbagen.2019.07.006. Epub 2019 Jul 12.
5
Regulation of TEAD Transcription Factors in Cancer Biology.TEAD 转录因子在癌症生物学中的调控作用。
Cells. 2019 Jun 17;8(6):600. doi: 10.3390/cells8060600.
6
PDK-1 mediated Hippo-YAP-IRS2 signaling pathway and involved in the apoptosis of non-small cell lung cancer cells.PDK-1 介导的 Hippo-YAP-IRS2 信号通路,并参与非小细胞肺癌细胞的凋亡。
Biosci Rep. 2019 May 14;39(5). doi: 10.1042/BSR20182099. Print 2019 May 31.
7
Daucosterol induces autophagic-dependent apoptosis in prostate cancer via JNK activation.大根香叶醇通过激活 JNK 诱导前列腺癌细胞发生自噬依赖性凋亡。
Biosci Trends. 2019 May 12;13(2):160-167. doi: 10.5582/bst.2018.01293. Epub 2019 Apr 2.
8
Systems Biology Analyses Show Hyperactivation of Transforming Growth Factor-β and JNK Signaling Pathways in Esophageal Cancer.系统生物学分析显示食管癌中转化生长因子-β和 JNK 信号通路的过度激活。
Gastroenterology. 2019 May;156(6):1761-1774. doi: 10.1053/j.gastro.2019.01.263. Epub 2019 Feb 12.
9
MiR-223-3p promotes cell proliferation and metastasis by downregulating SLC4A4 in clear cell renal cell carcinoma.在透明细胞肾细胞癌中,微小RNA-223-3p通过下调溶质载体家族4成员4促进细胞增殖和转移。
Aging (Albany NY). 2019 Jan 22;11(2):615-633. doi: 10.18632/aging.101763.
10
Integrated proximal proteomics reveals IRS2 as a determinant of cell survival in ALK-driven neuroblastoma.整合近端蛋白质组学揭示 IRS2 是 ALK 驱动神经母细胞瘤细胞存活的决定因素。
Sci Signal. 2018 Nov 20;11(557):eaap9752. doi: 10.1126/scisignal.aap9752.